Experimental group:Based on the results of organoid drug sensitivity, combined with clinical experience and patient condition, select a treatment plan.
Sponsors
Second Affiliated Hospital of Army Medical University, The First Affiliated Hospital of Chongqing Medical University
Conditions
Non-small cell lung cancer
Unknown Phase
Prospective open label single center clinical study guiding chemotherapy in drug-resistant NSCLC patients based on organoid drug sensitivity results
Active, not recruitingChiCTR2600121066
Start: 2026-03-31Updated: 2026-03-30
Clinical study on the treatment of non-small cell lung cancer patients with drug resistance/recurrence assisted by organoid drug sensitivity results
Active, not recruitingChiCTR2600127727
Start: 2026-07-30Updated: 2026-07-13